New Clarinol A95 Is Now the Highest Concentrated Form of Conjugated Linoleic Acid (CLA) Available to the Nutraceutical Industry
Channahon, Ill., August 20, 2004 - Lipid Nutrition, a global leader in lipid-based health ingredients, today announced that it has introduced Clarinol(TM) A95, the highest form of concentrated conjugated linoleic acid (CLA) available to the nutraceutical market.
Until recently, 80 percent was the highest form of active CLA isomers available with access to the WARF patent claims of reducing body fat and increasing lean muscle mass. Now, Clarinol(tm) A95 offers the highest form of active CLA isomers at 95 percent.
Clarinol(tm) A95 offers distinct advantages over the conventional 80 percent active CLA concentration offered by the competition -- it allows for a more highly concentrated 1-gram capsule or it enables manufacturers of nutraceutical products to offer a smaller capsule to the consumer.
"Clarinol(tm) A95 is the latest innovation of Lipid Nutrition's top-quality brand of CLA. Clarinol(tm) CLA was the first on the market with a triglyceride oil and then the first with a CLA Powder," said David R. Lewis, Business Unit Manager, North America, for Loders Croklaan Lipid Nutrition. "Now with Clarinol(tm) A95, the first and highest concentrated form of CLA, our customers have more options available they are trying to fill consumer needs. These are options that the competition does not currently offer."
Lipid Nutrition, a division of Loders Croklaan, is a global leader in the supply of scientifically sound lipid ingredients from natural origin, which improve and maintain health and well-being. The company offers a variety of branded products, including Clarinol(tm) for body weight management, Marinol(tm) concentrated fish oils for heart health and brain development, Membranol(tm) phosphatidyl choline enriched lecithin for liver health and memory improvement and Betapol(tm) human milk fat substitute for infant nutrition.